Unit of Functional and Adaptive Biology, Laboratory of Molecular and Cellular Responses to Xenobiotics, Université Paris Diderot, Paris, France.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 Mar-Apr;4(2):169-83. doi: 10.1002/wnan.166. Epub 2011 Dec 5.
Evaluation of the immunomodulatory potentials of nanomaterials is essential for developing safe and consumer-friendly nanotechnology. Various nanomaterials interact with the immune system, in a beneficial or deleterious way, but mechanistic details about such interactions are scarce. A lack of agreed-upon guidelines for evaluating the immunotoxicity of nanoparticles (NPs) adds to the complexity of the issue. Various review articles have summarized the immune system interactions of biodegradable NPs (with pharmaceutical uses), but such information is largely lacking for nonbiodegradable NPs. Here we give an overview of interactions of nonbiodegradable, persistent NPs with the immune system. Particular emphases include key factors that shape such interactions, cell-specific responses, allergy and immune-sensitive respiratory disorders.
评估纳米材料的免疫调节潜力对于开发安全、友好型的纳米技术至关重要。各种纳米材料以有益或有害的方式与免疫系统相互作用,但关于这种相互作用的机制细节还很缺乏。缺乏评估纳米颗粒(NPs)免疫毒性的公认指南,增加了问题的复杂性。各种综述文章总结了具有药物用途的可生物降解 NPs 与免疫系统的相互作用,但关于不可生物降解 NPs 的此类信息在很大程度上还很缺乏。在这里,我们概述了不可生物降解、持久性 NPs 与免疫系统的相互作用。特别强调的包括塑造这种相互作用的关键因素、细胞特异性反应、过敏和免疫敏感的呼吸道疾病。